Molecular Genetic Analysis of Fungal Circadian Rythms

真菌昼夜节律的分子遗传学分析

基本信息

  • 批准号:
    7893872
  • 负责人:
  • 金额:
    $ 32.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-08-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Organisms from bacteria to humans use a circadian clock to control daily biochemical, physiological, and behavioral rhythms. This clock affects human physiology, and disruptions of normal clock function can cause a variety of health problems. A considerable amount is known about the oscillators that form the core of the circadian timing system. However, the output pathways that connect oscillators to the activities they control are largely unknown. In humans, p38 mitogen-activated protein kinase (MAPK) pathways regulate cell proliferation, and mutations of pathway components, or alterations of pathway activity, are associated with cancer. We found that in Neurospora crassa the stress-induced p38 MAPK pathway is used as an output pathway from the FRQ/WCC circadian oscillator. Under non-stressed conditions, time-of-day information is passed from the oscillator through the MAPK signaling pathway at or upstream of the response regulator RRG-1, resulting in rhythmic p38 MAPK phosphorylation. Phospho-p38 MAPK then signals to transcription factors and other effector molecules, to regulate rhythms in gene expression. We hypothesize that circadian oscillators have co-opted cellular signaling pathways to control expression of clock-controlled genes (ccgs), and propose three specific aims to test this hypothesis. First, to elucidate the mechanism whereby ccgs are regulated by the clock, we will use available mutants to determine which p38 MAPK pathway components are necessary for clock regulation of the pathway. We will also determine which oscillator components are needed for this regulation. Secondly, again using available mutants, we will identify the transcription factor(s) that function downstream of the p38 MAPK to regulate rhythmic expression of ccg-1, a gene regulated by the p38 MAPK pathway. These results will allow us to describe, for the first time in any organism, a complete mechanism for rhythmic regulation of a ccg. Thirdly, to investigate whether co-opting cellular signaling pathways by the clock is a general mechanism for controlling rhythmic gene expression, we will determine if the clock regulates only p38, or p38 and other MAPK signaling pathways in Neurospora. Lastly, we will examine whether co-opting cellular signaling pathways by the clock is a conserved mechanism for controlling circadian rhythmicity by determining if the clock also regulates rhythmicity of the mammalian p38 pathway. Because the p38 kinases are known to regulate chromatin structure and translation, we will also investigate the exciting possibility that rhythmic p38 MAPK activity contributes to circadian rhythmicity by regulating chromatin remodeling and translational repression. Together, results from these aims will uncover the mechanisms by which circadian oscillators signal through the output pathways to control gene expression and may provide novel approaches for therapies to treat human diseases that result from circadian dysfunction and/or misregulation of the p38 MAPK pathway. PUBLIC HEALTH RELEVANCE Humans have an internal clock that regulates mechanisms such as the sleep/wake cycle and affects the response of cells to anti-cancer drugs and other pharmaceuticals. We found that the circadian clock in fungi regulates daily rhythms in the activity of p38 mitogen-activated protein kinase, which functions in mammals to suppress cancer cell formation. Understanding how the clock regulates the p38 pathway will facilitate efforts for developing new therapies for treating human diseases that result from clock dysfunction and/or misregulation of the p38 MAPK pathway.
描述(由申请人提供):从细菌到人类的生物体使用生物钟来控制日常生化,生理和行为节律。这种生物钟会影响人体生理,正常生物钟功能的中断会导致各种健康问题。我们对构成昼夜节律计时系统核心的振荡器有相当多的了解。然而,将振荡器与其控制的活动连接起来的输出路径在很大程度上尚不清楚。在人类中,p38丝裂原活化蛋白激酶(MAPK)通路调节细胞增殖,通路组分的突变或通路活性的改变与癌症相关。我们发现在粗糙脉孢菌中,应激诱导的p38 MAPK通路被用作FRQ/WCC昼夜节律振荡器的输出通路。在非应激条件下,一天中的时间信息从振荡器通过反应调节因子RRG-1处或上游的MAPK信号通路传递,导致有节奏的p38 MAPK磷酸化。然后磷酸化p38 MAPK向转录因子和其他效应分子发出信号,以调节基因表达的节律。我们假设昼夜节律振荡器已经增选细胞信号通路来控制时钟控制基因(ccgs)的表达,并提出了三个具体的目标来验证这一假设。首先,为了阐明CCGS受时钟调节的机制,我们将使用可用的突变体来确定哪些p38 MAPK通路组分是时钟调节通路所必需的。我们还将确定该调节需要哪些振荡器元件。其次,再次使用可用的突变体,我们将鉴定在p38 MAPK下游起作用以调节ccg-1(由p38 MAPK途径调节的基因)的节律表达的转录因子。这些结果将使我们能够首次在任何生物体中描述ccg节律调节的完整机制。第三,为了研究时钟是否是控制节律基因表达的一般机制,我们将确定时钟是否仅调节p38,或p38和其他MAPK信号通路在脉孢菌。最后,我们将研究是否coo-opting细胞信号通路的时钟是一个保守的机制,通过确定时钟是否也调节哺乳动物p38通路的节律性来控制昼夜节律。由于已知p38激酶调节染色质结构和翻译,我们还将研究节律性p38 MAPK活性通过调节染色质重塑和翻译抑制而促进昼夜节律性的令人兴奋的可能性。总之,这些目标的结果将揭示昼夜节律振荡器通过输出途径发出信号以控制基因表达的机制,并可能为治疗由昼夜节律功能障碍和/或p38 MAPK通路失调引起的人类疾病提供新的治疗方法。 人类有一个内部时钟,调节睡眠/觉醒周期等机制,并影响细胞对抗癌药物和其他药物的反应。我们发现真菌的生物钟调节p38丝裂原活化蛋白激酶活性的每日节律,p38丝裂原活化蛋白激酶在哺乳动物中起抑制癌细胞形成的作用。了解生物钟如何调节p38通路将有助于开发用于治疗由生物钟功能障碍和/或p38 MAPK通路失调引起的人类疾病的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deborah Bell-Pedersen其他文献

Deborah Bell-Pedersen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deborah Bell-Pedersen', 18)}}的其他基金

Mechanisms of Circadian Clock Control of mRNA Translation
mRNA 翻译的昼夜节律时钟控制机制
  • 批准号:
    10620952
  • 财政年份:
    2018
  • 资助金额:
    $ 32.01万
  • 项目类别:
Mechanisms of Circadian Clock Control of mRNA Translation
mRNA 翻译的昼夜节律时钟控制机制
  • 批准号:
    10400048
  • 财政年份:
    2018
  • 资助金额:
    $ 32.01万
  • 项目类别:
Mechanisms of Circadian Clock Control of mRNA Translation
mRNA 翻译的昼夜节律时钟控制机制
  • 批准号:
    10152622
  • 财政年份:
    2018
  • 资助金额:
    $ 32.01万
  • 项目类别:
Mechanisms of Circadian Clock Control of mRNA Translation
mRNA 翻译的昼夜节律时钟控制机制
  • 批准号:
    9923685
  • 财政年份:
    2018
  • 资助金额:
    $ 32.01万
  • 项目类别:
Systems Biology of the Circadian Clock Output Network
昼夜节律时钟输出网络的系统生物学
  • 批准号:
    9320381
  • 财政年份:
    2015
  • 资助金额:
    $ 32.01万
  • 项目类别:
Systems Biology of the Circadian Clock Output Network
昼夜节律时钟输出网络的系统生物学
  • 批准号:
    8838960
  • 财政年份:
    2015
  • 资助金额:
    $ 32.01万
  • 项目类别:
Biannual Meeting of the Society for Research on Biological Rhythms
生物节律研究学会每年两次的会议
  • 批准号:
    8716349
  • 财政年份:
    2014
  • 资助金额:
    $ 32.01万
  • 项目类别:
Determining the Mechanism of Temperature Compensation of the Circadian Clock
确定昼夜节律时钟的温度补偿机制
  • 批准号:
    8519815
  • 财政年份:
    2013
  • 资助金额:
    $ 32.01万
  • 项目类别:
Determining the Mechanism of Temperature Compensation of the Circadian Clock
确定昼夜节律时钟的温度补偿机制
  • 批准号:
    9061721
  • 财政年份:
    2013
  • 资助金额:
    $ 32.01万
  • 项目类别:
Determining the Mechanism of Temperature Compensation of the Circadian Clock
确定昼夜节律时钟的温度补偿机制
  • 批准号:
    8840613
  • 财政年份:
    2013
  • 资助金额:
    $ 32.01万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 32.01万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 32.01万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 32.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了